COM:ERYTECH
PHAXIAM Therapeutics
- Stock
Last Close
0.80
28/06 15:35
Market Cap
48.66M
Beta: -
Volume Today
27.49K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.10 - | ||||||||||
cash conversion cycle | 253.75 - | ||||||||||
cash per share | 3.22 - | 6.30 95.23% | 6.56 4.17% | 4.72 28.11% | 10.34 119.34% | 7.49 27.57% | 4.08 45.53% | 2.42 40.74% | 1.44 40.32% | 1.25 13.23% | |
company equity multiplier | 1.32 - | 1.13 14.20% | 1.12 0.78% | 1.26 12.20% | 1.08 14.70% | 1.15 7.10% | 1.39 20.20% | 3.03 118.66% | 2.92 3.53% | 1.95 33.26% | |
days of inventory outstanding | 9.47 - | 10.95 15.61% | 5.62 48.64% | 2.68 52.27% | 2.52 6.00% | 15.22 503.44% | 2.50 83.56% | ||||
days of payables outstanding | 97.38 - | 115.06 18.16% | 124.38 8.10% | 89.44 28.09% | 115.77 29.44% | 181.64 56.90% | 35.48 80.46% | 29.83 15.93% | |||
days of sales outstanding | 341.66 - | ||||||||||
dividend yield | |||||||||||
ebit per revenue | -3.93 - | ||||||||||
ebt per ebit | 1.16 - | 0.99 14.09% | 0.96 2.91% | 0.98 1.52% | 1.09 10.99% | 0.88 19.29% | 0.98 11.61% | 1.06 8.89% | 0.95 10.61% | -0.10 111.01% | |
effective tax rate | 0.00 - | 0.00 53.57% | 0.00 91.20% | -0.00 328.53% | 0.00 119.59% | -0.00 158.49% | 0.00 130.50% | -0.00 356.46% | -0.00 9.17% | 1.78 4,782,897.78% | |
enterprise value multiple | -4.06 - | -14.29 252.03% | -9.09 36.37% | -3.49 61.64% | -4.52 29.62% | 0.54 111.96% | -1.00 284.86% | -1.67 67.38% | -0.88 47.25% | 0.61 169.09% | |
fixed asset turnover | 2.27 - | ||||||||||
free cash flow per share | -1.47 - | -1.30 11.46% | -2.13 63.66% | -2.43 13.67% | -1.47 39.34% | -2.98 102.70% | -3.54 18.60% | -2.87 18.71% | -2.41 16.22% | -1.03 57.37% | |
gross profit margin | -1.96 - | ||||||||||
interest coverage | -1.52K - | -1.32K 13.54% | -3.12K 136.89% | -5.60K 79.59% | -2.06K 63.21% | -4.85K 135.38% | -41.80 99.14% | -12.86 69.24% | -26.43 105.61% | -2.05 92.25% | |
inventory turnover | 38.54 - | 33.34 13.50% | 64.92 94.72% | 135.99 109.49% | 144.67 6.38% | 23.97 83.43% | 145.79 508.11% | ||||
long term debt to capitalization | 0.05 - | 0.01 76.43% | 0.00 73.44% | 0.07 2,193.08% | 0.01 84.96% | 0.01 23.13% | 0.13 1,416.36% | 0.47 266.52% | 0.51 7.55% | 0.30 40.04% | |
net income per ebt | 1.00 - | 1.00 0.26% | 1.00 0.21% | 1.00 0.07% | 1.00 0.06% | 1.00 0.01% | 1.00 0.01% | 1.00 0.01% | 1.00 0.00% | -0.78 177.81% | |
net profit margin | -4.52 - | ||||||||||
operating cash flow per share | -1.38 - | -1.23 10.80% | -2.10 70.05% | -2.21 5.30% | -1.38 37.58% | -2.19 58.98% | -2.41 10.29% | -2.81 16.50% | -2.40 14.82% | -1.02 57.26% | |
operating cycle | 351.13 - | ||||||||||
operating profit margin | -3.93 - | ||||||||||
payables turnover | 3.75 - | 3.17 15.37% | 2.93 7.49% | 4.08 39.06% | 3.15 22.74% | 2.01 36.26% | 10.29 411.89% | 12.24 18.95% | |||
pretax profit margin | -4.54 - | ||||||||||
price fair value | 3.43 - | 4.44 29.53% | 3.79 14.57% | 3.08 18.87% | 1.83 40.57% | 0.77 57.91% | 1.40 82.43% | 4.93 250.68% | 2.20 55.37% | 0.48 77.97% | |
receivables turnover | 1.07 - | ||||||||||
return on assets | -0.45 - | -0.22 51.92% | -0.28 29.81% | -0.49 72.05% | -0.17 64.76% | -0.23 32.62% | -0.53 132.09% | -0.91 72.48% | -0.81 11.62% | -0.00 99.38% | |
return on capital employed | -0.49 - | -0.25 49.85% | -0.33 33.60% | -0.58 76.28% | -0.17 70.99% | -0.30 76.21% | -0.65 119.13% | -1.35 107.60% | -1.21 10.36% | -0.08 93.22% | |
return on equity | -0.60 - | -0.25 58.74% | -0.32 28.79% | -0.61 93.04% | -0.18 69.94% | -0.26 42.04% | -0.73 178.97% | -2.76 277.14% | -2.35 14.74% | -0.01 99.59% | |
total debt to capitalization | 0.07 - | 0.02 69.66% | 0.01 29.62% | 0.07 402.95% | 0.02 79.26% | 0.01 11.37% | 0.14 935.47% | 0.51 258.83% | 0.53 3.50% | 0.37 30.42% |
All numbers in (except ratios and percentages)